Why the U.K. is seeing an uptick in COVID-19 cases

The United Kingdom is experiencing an uptick in coronavirus cases. It's "tiny" compared to previous spikes, David Leonhardt writes in The New York Times, but he adds that the country will still be "important to watch" in the next few weeks. So, considering the U.K. has had a mostly successful vaccine rollout, why is the increase happening?
The primary culprit is likely the more transmissible Delta variant, first identified in India, that's been spreading in the U.K. The good news is that it appears vaccines hold up pretty well against the mutatated virus, but less so for people who have received only one vaccine dose, which is more common in the U.K. than it is in the United States. The U.K. chose to prioritize first shots early in the rollout, which allowed a wider swath of people to get at least some protection. That was "not necessarily" a mistake, despite the Delta variant changing the game a bit, Leonhardt writes, but it does mean more people — especially younger people who are still in the middle of the vaccination process — have a higher risk of getting infected. Fortunately, about 90 percent of U.K. residents older than 65 have received both doses, and the country "is accelerating second shots for vulnerable people" now, Leonhardt writes.
Dr. Monica Gandhi, who specializes in infectious diseases at the University of California, San Francisco, also pointed out that the U.K. "does a lot of asymptomatic testing" even among the vaccinated population, which may play a role in the increase in cases and help explain why, for now at least, they aren't accompanied by rises in hospitalizations and deaths.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Quiz of The Week: 15 - 21 February
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published